Data is not available at this time.
Japan Transcity Corporation operates as a diversified logistics provider with a strong foothold in Japan and select international markets. The company’s core revenue streams stem from warehousing, freight forwarding, multimodal transportation, and specialized pharmaceutical logistics, positioning it as a key player in integrated freight solutions. Its ancillary businesses, including power generation, property leasing, and equipment trading, add resilience to its revenue model. Japan Transcity’s long-standing presence since 1895 underscores its deep industry expertise and trusted market position. The company differentiates itself through value-added services like pharmaceutical packaging and labeling, catering to high-compliance sectors. While competition in logistics remains intense, its diversified service portfolio and strategic focus on high-growth segments like healthcare logistics provide a competitive edge. The firm’s regional hub in Yokkaichi enhances its operational efficiency, supporting its reputation as a reliable partner for complex supply chain needs.
Japan Transcity reported revenue of JPY 122.6 billion for FY 2024, with net income of JPY 4.6 billion, reflecting a net margin of approximately 3.8%. Operating cash flow stood at JPY 7.3 billion, though capital expenditures of JPY 18.0 billion indicate significant reinvestment. The company’s profitability metrics suggest moderate efficiency, with room for optimization given the capital-intensive nature of logistics operations.
The firm’s diluted EPS of JPY 72.53 demonstrates steady earnings power, supported by its diversified logistics and ancillary businesses. However, high capital expenditures relative to operating cash flow highlight the sector’s capital intensity. Japan Transcity’s ability to maintain profitability amid these demands underscores its operational discipline, though further improvements in capital turnover could enhance returns.
Japan Transcity holds JPY 22.0 billion in cash and equivalents against total debt of JPY 41.7 billion, indicating a manageable leverage position. The balance sheet reflects a typical logistics firm’s structure, with significant investments in fixed assets. Liquidity appears adequate, but the debt load warrants monitoring given the cyclicality of freight demand and capital expenditure requirements.
The company’s growth is likely tied to Japan’s logistics demand and its expansion in specialized services like pharmaceutical logistics. A dividend per share of JPY 39 suggests a commitment to shareholder returns, though the payout ratio remains conservative, aligning with the sector’s reinvestment needs. Future growth may hinge on operational scalability and international market penetration.
With a market cap of JPY 57.3 billion and a beta of 0.48, Japan Transcity is perceived as a relatively stable investment within the industrials sector. The valuation reflects moderate growth expectations, balancing its established market position against the competitive and capital-intensive logistics landscape.
Japan Transcity’s strategic advantages include its diversified service mix, long-term industry relationships, and focus on high-margin niches like healthcare logistics. Near-term challenges include managing capex and debt, but its entrenched market position and adaptability position it well for steady, if unspectacular, growth in a fragmented industry.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |